Differential Sorting of Human δ-Opioid Receptors after Internalization by Peptide and Alkaloid Agonists*

Desensitization and internalization of G protein-coupled receptors observed after agonist activation are considered two important regulatory processes of receptor transduction. Endogenous human δ-opioid receptors (hDOR) are differentially regulated in terms of desensitization by peptide ([d-Pen2,5]enkephalin (DPDPE) and Deltorphin I) and alkaloid (etorphine) agonists in the neuroblastoma cell line SK-N-BE (Allouche, S., Roussel, M., Marie, N., and Jauzac, P. (1999) Eur. J. Pharmacol. 371, 235–240). In the present study, we examined the role of hDOR internalization and down-regulation in this differential desensitization. Sustained activation by peptides for 30 min caused a marked decrease of both [3H]diprenorphine binding sites and hDOR immunoreactivity, observed in a Western blot, whereas a moderate reduction by 30% was observed after a 30- and 60-min etorphine exposure in binding experiments without opioid receptor degradation. Using fluorescence microscopy, we visualized hDOR internalization promoted by different agonists in SK-N-BE cells expressing FLAG-tagged hDOR. Agonist withdrawal results in a greater recycling process correlated with a stronger hDOR resensitization after etorphine treatment compared with DPDPE or Deltorphin I, as shown in binding, immunocytochemical, and functional experiments. This suggests a distinct sorting of opioid receptors after their internalization. We demonstrated a lysosomal hDOR targeting upon peptides by using chloroquine in binding, Western blot, and immunocytochemical experiments and by colocalization of this receptor with a late endosome marker. In contrast, when the recycling endosome blocker monensin was used, acceleration of desensitization associated with a strong intracellular immunostaining was observed upon etorphine treatment. The possibility of separate endocytic pathways responsible for the differential sorting of hDOR upon peptide and alkaloid ligand exposure was ruled out by binding and immunocytochemical experiments using sucrose hypertonic solution. First, these results showed complex relationships between hDOR internalization/down-regulation and desensitization. Second, we demonstrated for the first time that the same receptor could undergo a distinct sorting after internalization by peptide and alkaloid agonists.

[1]  K. Chaturvedi,et al.  Proteasome Involvement in Agonist-induced Down-regulation of μ and δ Opioid Receptors* , 2001, The Journal of Biological Chemistry.

[2]  S. Ferguson,et al.  Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. , 2001, Pharmacological reviews.

[3]  H. Loh,et al.  Deltorphin II-induced Rapid Desensitization of δ-Opioid Receptor Requires Both Phosphorylation and Internalization of the Receptor* , 2000, The Journal of Biological Chemistry.

[4]  M. von Zastrow,et al.  Type-specific Sorting of G Protein-coupled Receptors after Endocytosis* , 2000, The Journal of Biological Chemistry.

[5]  D. Massotte,et al.  Internalization and recycling of delta-opioid receptor are dependent on a phosphorylation-dephosphorylation mechanism. , 2000, The Journal of pharmacology and experimental therapeutics.

[6]  Y. Okamoto,et al.  Cholesterol Oxidation Switches the Internalization Pathway of Endothelin Receptor Type A from Caveolae to Clathrin-coated Pits in Chinese Hamster Ovary Cells* , 2000, The Journal of Biological Chemistry.

[7]  M. Caron,et al.  Association of β-Arrestin with G Protein-coupled Receptors during Clathrin-mediated Endocytosis Dictates the Profile of Receptor Resensitization* , 1999, The Journal of Biological Chemistry.

[8]  A. Strosberg,et al.  Beta(2)-adrenergic receptor down-regulation. Evidence for a pathway that does not require endocytosis. , 1999, The Journal of biological chemistry.

[9]  S. Allouche,et al.  Differential G-protein activation by alkaloid and peptide opioid agonists in the human neuroblastoma cell line SK-N-BE. , 1999, The Biochemical journal.

[10]  H. Loh,et al.  Visualization of time-dependent redistribution of delta-opioid receptors in neuronal cells during prolonged agonist exposure. , 1999, Brain research. Molecular brain research.

[11]  M. Bünemann,et al.  G‐protein coupled receptor kinases as modulators of G‐protein signalling , 1999, The Journal of physiology.

[12]  S. Allouche,et al.  Differential desensitization of human δ-opioid receptors by peptide and alkaloid agonists , 1999 .

[13]  J. Benovic,et al.  U50,488H-induced Internalization of the Human κ Opioid Receptor Involves a β-Arrestin- and Dynamin-dependent Mechanism , 1999, The Journal of Biological Chemistry.

[14]  S. Coughlin,et al.  Termination of signaling by protease-activated receptor-1 is linked to lysosomal sorting. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[15]  R. Alexander,et al.  Angiotensin II type 1 receptor: relationship with caveolae and caveolin after initial agonist stimulation. , 1998, Hypertension.

[16]  S. Schulz,et al.  Carboxyl-terminal Splicing of the Rat μ Opioid Receptor Modulates Agonist-mediated Internalization and Receptor Resensitization* , 1998, The Journal of Biological Chemistry.

[17]  D. Massotte,et al.  Desensitization of the δ‐Opioid Receptor Correlates with Its Phosphorylation in SK‐N‐BE Cells: Involvement of a G Protein‐Coupled Receptor Kinase , 1998, Journal of neurochemistry.

[18]  B. Ashby,et al.  Agonist-induced desensitization and down-regulation of the human kappa opioid receptor expressed in Chinese hamster ovary cells. , 1998, The Journal of pharmacology and experimental therapeutics.

[19]  R. Parton,et al.  A lipid associated with the antiphospholipid syndrome regulates endosome structure and function , 1998, Nature.

[20]  T. Reisine,et al.  Opioid regulation of the mouse delta-opioid receptor expressed in human embryonic kidney 293 cells. , 1997, Molecular pharmacology.

[21]  L. M. Leeb-Lundberg,et al.  Bradykinin Sequesters B2 Bradykinin Receptors and the Receptor-coupled Gα Subunits Gαq and Gαiin Caveolae in DDT1 MF-2 Smooth Muscle Cells* , 1997, The Journal of Biological Chemistry.

[22]  S. Allouche,et al.  The δ‐Opioid Receptor in SK‐N‐BE Human Neuroblastoma Cell Line Undergoes Heterologous Desensitization , 1997, Journal of neurochemistry.

[23]  B. O'dowd,et al.  Agonist-induced functional desensitization of the mu-opioid receptor is mediated by loss of membrane receptors rather than uncoupling from G protein. , 1996, Molecular pharmacology.

[24]  J. Bidlack,et al.  The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line down-regulates without desensitizing during chronic opioid exposure. , 1995, The Journal of pharmacology and experimental therapeutics.

[25]  J. Benovic,et al.  Molecular mechanisms of agonist-induced desensitization of the cloned mouse kappa opioid receptor. , 1994, The Journal of pharmacology and experimental therapeutics.

[26]  P. Law,et al.  Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SHSY5Y cells. , 1994, The Journal of pharmacology and experimental therapeutics.

[27]  J. Meunier,et al.  SK‐N‐BE: A Human Neuroblastoma Cell Line Containing Two Subtypes of δ‐Opioid Receptors , 1994 .

[28]  G. Pasternak Pharmacological mechanisms of opioid analgesics. , 1993, Clinical neuropharmacology.

[29]  G A McPherson,et al.  Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC. , 1985, Journal of pharmacological methods.

[30]  David R. Sibley,et al.  Molecular mechanisms of receptor desensitization using the β-adrenergic receptor-coupled adenylate cyclase system as a model , 1985, Nature.

[31]  H. Loh,et al.  Molecular mechanisms and regulation of opioid receptor signaling. , 2000, Annual review of pharmacology and toxicology.